Discover what distinguishes Georgetown Lombardi Comprehensive Cancer Center,
Washington, D.C.’s only National Cancer Institute-designated Comprehensive Cancer Center.

About Georgetown Lombardi

A man stands at a podium, gesturing as he delivers a talkRuesch Center Symposium: Innovations in GI Cancer

A unique forum for discussion, networking and debate of critical issues related to GI cancers: Nov. 30 & Dec. 1 at the Washington Hilton

Register Now


Lombardi News Stories

  • A bare tree stands against a white background
    More Clues Revealed in Link Between Normal Breast Changes and Invasive Breast Cancer

    A research team led by investigators from Georgetown Lombardi Comprehensive Cancer Center has published the results of a mouse study that shows how changes in mammary glands to accommodate breastfeeding use a molecular process believed to contribute to the survival of premalignant breast cells.

  • Image of the Georgetown University Medical and Dental building taken in the evening
    Mouse Study Mirrors Human Findings That Link Chemotherapy and APOE4 to Cognitive Issues

    New research by Georgetown University Medical Center investigators indicates that a chemotherapy drug commonly used to treat breast cancer alters brain structure and function in mice that express the human APOE4 gene, which is known to significantly increase the risk of developing Alzheimer’s disease.

  • An outdoor view of the Lombardi Atrium entrance
    First Large Study Details Cognitive Outcomes Among Older Breast Cancer Patients

    The first large U.S. study of cognition in older breast cancer patients, led by researchers from Georgetown Lombardi Comprehensive Cancer Center, indicates that within the first two years after diagnosis and treatment, most women do not experience cancer-related cognitive problems.

  • The image of Alfred Nobel is shown on a bronze circle
    Nobel Prize-Winning Science is Key to New Treatments for Cancer

    The science that earned two researchers the Nobel Prize in Physiology or Medicine for 2018 — the discovery of cancer therapy by inhibition of negative immune regulation — is at the heart of an increasing number of standard treatments and many ongoing clinical trials at Georgetown Lombardi Comprehensive Cancer Center.